An echogenic intracardiac focus (EIF) is a relatively common finding, even in otherwise normal fetuses. It is not a structural abnormality, but rather represents calcified deposits in the fetal heart that appear as bright spots on prenatal ultrasound.
When seen in isolation, with no other fetal abnormalities
If other anomalies are detected:
An EIF is the presence of echogenic tissue in one or both of the cardiac ventricles, and is observed on the four chamber fetal cardiac view. EIFs may also be referred to as a Papillary Muscle Calcification. EIFs are a fairly common second trimester subjective finding, seen in 4-7% of euploid fetuses and in 15-30% of fetuses with Trisomy 21/Down syndrome. Multiple, bilateral or prominent EIFs are associated with slightly higher aneuploidy risk in some studies.
ACOG Practice Bulletin 226: Screening for Fetal Chromosomal Abnormalities
ACOG Practice Bulletin 162: Prenatal Diagnostic Testing for Genetic Disorders
ACOG Practice Bulletin 175: Ultrasound in Pregnancy
Maternal Fetal Medicine Specialist Locator-SMFM
Take a post-test and get CME credits
Please sign up or log in to your ObGFirst to access this Premium Content
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
